Mirae Asset Global ETFs Holdings’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$223K Sell
96,543
-6,531
-6% -$15.1K ﹤0.01% 2223
2025
Q1
$143K Sell
103,074
-5,530
-5% -$7.69K ﹤0.01% 2476
2024
Q4
$188K Buy
108,604
+20,551
+23% +$35.6K ﹤0.01% 2412
2024
Q3
$177K Buy
+88,053
New +$177K ﹤0.01% 2421